Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02290691 · ClinicalTrials.gov registry record · Phase 4
Inactivated Influenza Via Jet Injection
A Phase 4 study, sponsored by PharmaJet.
- Completed
- Registry status
- Phase 4
- Development phase
- 985
- Enrollment target
NCT02290691: Completed Phase 4 study, sponsored by PharmaJet.
NCT02290691 is a Phase 4 study that has completed, run by PharmaJet. The registered enrollment target is 985 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02290691, a Phase 4 study, has completed, sponsored by PharmaJet.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 985 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the administration of flu vaccine using Needle-Free is equivalent to Needle and Syringe administration as measured by laboratory tests of immune response.
Primary Outcome
The GMT criterion for non-inferiority for the upper limit of the 95% CIs of the GMT ratio (GMT with Needle-Free / GMT with Needle and Syringe) antigen will not exceed 1.5 fold.
Interventions
- BIOLOGICAL Influenza Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 985 participants |
| Start Date | 2014-11 |
| Est. Completion | 2015-01 |
| Phase | Phase 4 |
What the finished NCT02290691 record still lists
NCT02290691 is an interventional study that assigns participants to a tested intervention. The registered 985 participants enrollment target is mid-sized for trials with a published cap, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% higher).
The record links to 0 conditions, and to 1 intervention - of which Influenza Vaccine is the first listed.
NCT02290691 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02290691 about?
NCT02290691 is a clinical study titled "Inactivated Influenza Via Jet Injection". The purpose of this study is to determine if the administration of flu vaccine using Needle-Free is equivalent to Needle and Syringe administration as measured by laboratory tests of immune response.
What is the current status of trial NCT02290691?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 985 participants. The study started on 2014-11. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02290691?
The interventions under investigation include: Influenza Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT02290691?
This trial is sponsored by PharmaJet, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02290691's enrollment target sits among peer trials
985 75th of 2000 higher than 1,926 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05079841 · 988 participants · Phase 4
The Stimulation To Induce Mothers Study
- NCT06989437 · 982 participants · Phase 2
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- NCT06959095 · 981 participants · Phase 3
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- NCT05441709 · 990 participants · NA
Furthering Equity Through Infant Feeding EDucation and Support
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia